NO-CANCER-NET (Advanced Engineering of Nitric Oxide Based Therapeutics for Triple Negative Breast Cancer Training Network) is a 4-year, €2.7million Horizon Europe MSCA Doctoral Network Grant award from the European Research Executive Agency to address unmet medical need for Triple Negative Breast Cancer (TNBC).

The network is led by Professor Sharon Glynn, Fulbright Scholar and Professor in Pathology at University of Galway in collaboration with CÚRAM. The network will train 10 doctoral candidates across 6 European countries and 9 institutions, focussing on three areas centred on expanding nitric oxide (NO) based therapeutics for the treatment of TNBC